U.S. markets closed

Foghorn Therapeutics Inc. (FHTX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W
19.52+0.54 (+2.85%)
At close: 4:00PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
Total Revenue
179
0
0
Operating Expense
63,117
51,084
26,049
Operating Income
-62,938
-51,084
-26,049
Net Non Operating Interest Income Expense
-328
-45
-258
Other Income Expense
-
1
-30
Pretax Income
-63,334
-51,128
-26,337
Net Income Common Stockholders
-63,335
-51,129
-26,337
Diluted NI Available to Com Stockholders
-63,335
-51,129
-26,337
Basic EPS
-
-0.0026
-0.0013
Diluted EPS
-
-0.0026
-0.0013
Basic Average Shares
-
19,629
19,629
Diluted Average Shares
-
19,629
19,629
Total Operating Income as Reported
-62,938
-51,084
-26,049
Total Expenses
63,117
51,084
26,049
Net Income from Continuing & Discontinued Operation
-63,334
-51,128
-26,337
Normalized Income
-63,334
-51,129
-26,307
Interest Income
508
495
113
Interest Expense
836
540
371
Net Interest Income
-328
-45
-258
EBIT
-62,498
-50,588
-25,966
EBITDA
-61,501
-
-
Reconciled Depreciation
997
693
379
Net Income from Continuing Operation Net Minority Interest
-63,334
-51,128
-26,337
Total Unusual Items Excluding Goodwill
-
1
-30
Total Unusual Items
-
1
-30
Normalized EBITDA
-61,501
-49,896
-25,557
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0

Premium access required.

Learn more